Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | BOARD MEETINGS
BOARD MEETINGS
Viaan Industries Ltd.
BSE CODE: 537524   |   ISIN CODE : INE324N01027
BSE
0.91
0 ( 0% )
 
Prev Close ( Rs.)
0.91
Open ( Rs.)
0.91
 
High ( Rs.)
0.91
Low ( Rs.)
0.91
 
Volume
18427
Week Avg.Volume
NA
 
52 WK High-Low Range
BSE NSE
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range
Source DateBoard Meeting DateDetails
24-Apr-2024 06-May-2024 Inter alia, to consider and approve:- 1.To approve the alteration of main object clause 2.To approve the appointment of Vasisht & Associates, PR No. 2355/2022 as Secretarial Auditor 3.To take note of vacation of office of Ms. Dolly Dhandhresha 4.To approve the appointment of Mr. Hemant Jindal as managing director 5.To approve the appointment of Mr. Dinesh Birla (DIN-089001653) as an Additional Director (Ind. Director) 6.To approve the appointment of Mr. Keshav Rathi (DIN-07288145) as an Additional Director (Ind. Director) 7.To approve the appointment of Ms. Bhavika Mehta as an Additional Director (Ind. Director) 8.To approve the appointment of Ms. Teena Goel as Compliance Officer 9.To fix the record date for cancellation and issuance of share capital as per resolution plan 10. To consider and approve the appointment of M/s. S.C. Garg & Associates, Chartered Accountants (FRN: 006873N), as the Internal Auditor 11. To appoint Ashwani & Associates (FRN- 000497N), Chartered Accountant as Statutory Auditors of Comp
10-Feb-2022 14-Feb-2022 Quarterly Results
08-Nov-2021 14-Nov-2021 Quarterly Results
24-Aug-2021 27-Aug-2021 A.G.M.
05-Aug-2021 14-Aug-2021 Quarterly Results
09-Jul-2021 14-Jul-2021 Reduction of Capital & Inter alia: (i) To consider and approve draft scheme of Reduction of Share Capital of the company and other related matters. (ii) Any other matter with the permission of chair.
03-Jun-2021 12-Jun-2021 Reduction of Capital & Audited Results inter alia: (i) To discuss and approve the Standalone audited Financial Result for the quarter and year ended 31° March, 2021 (Financial year 2020-2021) along with the Audit Report for the said period. (ii) To consider, discuss and approve change in designation of Mr. Sumit Mehra from Whole-time Director to Managing Director subject to approval of Shareholders of the Company (iii) To consider and approve scheme of Reduction of Share Capital of the company and other related matters. (iv) Any other matter with the permission of chair.
24-Mar-2021 30-Mar-2021 Inter alia: 1. To consider appointment of Mr. Sumit Vijay Mehra as the Managing Director of the Company with effect from 30th March, 2021. 2. Any other matter with the permission of chair.
27-Jan-2021 12-Feb-2021 Reduction of Capital & Quarterly Results Inter alia, to consider and approve (i) The Standalone and Consolidated Unaudited Financial Result for the Quarter and Nine Month ended 31st December, 2020. (ii) Scheme of Reduction of Share Capital of the company and other related matters. (iii) Any other matter with the permission of chair.
17-Dec-2020 19-Dec-2020 Inter alia, to consider and approve 1. To discuss, consider and approve the resignation of Mr. Darshit Shah, Executive Director and CFO, of the Company, from the position of Director and Chief Financial Officer of Viaan Industries Limited with effect from 31st December, 2020. 2. To consider appointment of Mr. Umesh Kamat as the Managing Director of the Company with effect from 19th December, 2020. 3. To consider and approve appointment of Mr. Satyajit Kolay, as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company with effect from 1st January, 2021. 4. Any other business with the permission of Chairman.
Page 1 of 6
PREV || NEXT
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: INZ000271235 | DP~IN-DP 672-2022 | Member ID : NSE :14453 | BSE: 6281 | MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110
Segregation and Monitoring of Collateral at Client Level with reference to NCL circulars NCL/CMPL/49348 dated August 20, 2021, NCL/CMPL/49640 dated September 17, 2021 and NCL/CMPL/49764 dated September 29, 2021 on the captioned subject
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 dated August 31, 2020 and other guidelines issued from time to time in this regard 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors. "

BSE
×